LISANTI CAPITAL GROWTH, LLC – Halozyme Therapeutics, Inc. Transaction History
LISANTI CAPITAL GROWTH, LLC portfolio value:
$0
portfolio value
LISANTI CAPITAL GROWTH, LLC quarter portfolio value change:
-10.14%
quarter
Halozyme Therapeutics, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -100.00% | -350.93K shares | -15.44M | $39.54 | 0 |
| Q2 2022 | share | Increase | 0.00% | 350.93K shares | 15.44M | $44 | 350.93K |
| Q2 2021 | share | Decrease | -100.00% | -263.46K shares | -10.98M | $45.41 | 0 |
| Q1 2021 | share | Increase | 0.00% | 263.46K shares | 10.98M | $41.69 | 263.46K |
| Q1 2016 | share | Decrease | -100.00% | -29.96K shares | -519K | $9.47 | 0 |